Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-10-09
1977-08-16
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2523011R, A61K 2900, A61K 4300
Patent
active
040426769
ABSTRACT:
An improved technetium-99m labeled colloid and method of preparation comprising reducing technetium-99m with stannous oxalate and stabilizing with sodium phytate. This radiodiagnostic agent is useful in the scintigraphic examination of the recticuloendothelial system, particularly the liver. In addition, by autoclaving this product with saline, it becomes a superior bone marrow scanning agent.
REFERENCES:
patent: 3875299 (1975-04-01), Winchell et al.
Aburano et al., Life Sciences, vol. 12, June 30, 1975, Abstract No. 33622, p. 3371.
Columbetti, Radiobiol.-Radiother, Jan. 1974, pp. 47-51.
Johnson et al., Journ. of Nuclear Medicine, vol. 11, No. 1, (1970) pp. 564-565.
Sewakar et al., Nuclear Medicine, vol. XIV, No. 1, Mar. 31, 1975, pp. 46-51.
Subrumanian et al., J. of Nucl. Med., vol. 11, No. 6, 1970, pp. 365-366.
Molinski Victor Joseph
Peacock Frank Raymond
Blum Israel
Nucker Christine M.
Padgett Benjamin R.
Union Carbide Corporation
LandOfFree
Technetium-99m labeled radiodiagnostic agents for liver and bone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99m labeled radiodiagnostic agents for liver and bone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99m labeled radiodiagnostic agents for liver and bone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-361594